Article metrics
PDF
Other content recommended for you
- Does tranexamic acid improve outcomes in traumatic brain injury?
- Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach
- Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients
- Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen
- Nutritional blindness from avoidant-restrictive food intake disorder – recommendations for the early diagnosis and multidisciplinary management of children at risk from restrictive eating
- Controversies and evidence gaps in the early management of severe traumatic brain injury: back to the ABCs
- Prehospital management of severe traumatic brain injury
- Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study)
- Head injury: assessment and early management—summary of updated NICE guidance
- Prehospital tranexamic acid: what is the current evidence?